🇺🇸 FDA

Intelligence Platform

Patents

Browse 4 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11969424

Levosimendan for treating pulmonary hypertension with heart failure with preserved ejectio

TENAX THERAPEUTICS, INC. · Granted Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11701355

Levosimendan for treating pulmonary hypertension with heart failure with preserved ejectio

TENAX THERAPEUTICS, INC. · Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11607412

Levosimendan for treating pulmonary hypertension with heart failure with preserved ejectio

TENAX THERAPEUTICS, INC. · Granted Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11213524

Pharmaceutical compositions for subcutaneous administration of levosimendan

TENAX THERAPEUTICS, INC. · Granted Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted